Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: A double-blind, randomized, placebo-controlled study

Journal of Rheumatology

Volumn 37, Issue 10, 2010, Pages 2156-2166

  Moldofsky, Harvey ^a   Inhaber, Neil H ^b   Guinta, Diane R ^c   Alvarez Horine, Sarah B ^d  

^a Toronto Psychiatric Research Foundation   (Canada)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Clinical Development and Scientific Affairs   (United States)

^d JAZZ PHARMACEUTICALS   (United States)

Author keywords

Fatigue; Fibromyalgia; Polysomnography; Sodium oxybate

Indexed keywords

OXYBATE SODIUM; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; EPWORTH SLEEPINESS SCALE; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROLOGIC DISEASE; PAIN; PAIN ASSESSMENT; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REM SLEEP; RESTLESSNESS; SCREENING TEST; SHORT FORM 36; SLEEP APNEA SYNDROME; SLEEP WAKING CYCLE; STRUCTURED QUESTIONNAIRE; URINE INCONTINENCE; VISUAL ANALOG SCALE;

ADJUVANTS, ANESTHESIA; ADULT; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PLACEBOS; POLYSOMNOGRAPHY; QUESTIONNAIRES; SLEEP; SLEEP DISORDERS; SODIUM OXYBATE; TREATMENT OUTCOME;

EID: 77957870727     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.091041     Document Type: Article

References (47)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
2. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskel Disord 2007;8:27.
3. Hauser W, Zimmer C, Felde E, Kollner V. [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association.] Schmerz 2008;22:176-83.
4. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. Arthritis Care Res 2008;59:951-67.
5. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, et al; OMERACT Fibromyalgia Working Group. Fibromyalgia syndrome module at OMERACT 9: Domain construct. J Rheumatol 2009;36:2318-29.
6. Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 1996;68:363-8.
7. Hamilton NA, Affleck G, Tennen H, Karlson C, Luxton D, Preacher KJ, et al. Fibromyalgia: The role of sleep in affect and in negative event reactivity and recovery. Health Psychol 2008;27:490-7.
8. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and NREM sleep disturbances in patients with "fibrositis" syndrome and healthy subjects. Psychosom Med 1975;37:341-51.
9. Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. J Joint Bone Spine 2008;75:397-402.
10. Branco J, Atalaia A, Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 1994;21:1113-7.
11. Drewes AM, Gade J, Nielsen KD, Bjerregård K, Taagholt SJ, Svendsen L. Clustering of sleep encephalographic patterns in patients with the fibromyalgia syndrome. Br J Rheumatol 1995;34:1151-6.
12. Roizenblatt S, Moldofsky H, Benedito AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001;44:222-30.
13. Roizenblatt S, Tufik S, Goldenberg J, Pinto LR, Hilario MO, Feldman D. Juvenile fibromyalgia. Clinical and polysomnographic aspects. J Rheumatol 1997;24:579-85.
14. Anch A, Lue F, McLean A, Moldofsky H. Sleep physiology and psychological aspects of fibrositis syndrome. Can J Psychol 1991;45:179-84.
15. Chervin RD, Teodorescu M, Kushwaha R, Andrea M, Deline AM, Brucksch CB, et al. Objective measures of disordered sleep in fibromyalgia. J Rheumatol 2009;36:2009-16.
16. Landis CA, Lentz MJ, Rothermel J, Buchwald D, Shaver JL. Decreased sleep spindles and spindle activity in midlife women with fibromyalgia and pain. Sleep 2004;27:741-50.
17. Burns JW, Crofford LJ, Chervin RD. Sleep stage dynamics in fibromyalgia patients and controls. Sleep Med 2008;9:689-96.
18. Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, Andreoli A, Pecis M, et al. Cyclical alternating pattern: A new marker for sleep alteration in patients with fibromyalgia. J Rheumatol 2004;34:1193-9.
19. Hicks RA, Coleman DD, Ferrante F, Sahatjian M, Hawkins J. Pain thresholds in rats during recovery from REM sleep deprivation. Percept Mot Skills 1979;48:687-90.
20. Hakki Onen S, Alloui A, Jourdan D, Eschalier A, Dubray C. Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 2001;900:261-7.
21. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35-44.
22. Older SA, Battafarano DF, Danning CL, Ward JA, Grady EP, Derman S, et al. The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor. Int J Rheumatol 1998;25:1180-6.
23. Lentz MJ, Landis CA, Rothermel J, Shaver JL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999;26:1586-92.
24. Onen SH, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. Sleep Res 2001;10:35-42.
25. Kundermann B, Spernal J, Huber MT, Krieg JC, Lautenbacher S. Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 2004;66:932-7.
26. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006;29:145-51.
27. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007;30:494-505.
28. Reynolds WJ, Moldofsky H, Saskin P, Lue FA. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991;18:452-4.
29. Carette S, Oakson G, Guimont C, Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995;38:1211-7.
30. Drewes AM, Andreasen A, Jennum P, Nielsen KD. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20:288-93.
31. Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996;23:529-33.
32. Mamelak M, Black J, Montplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 2004;27:1327-34.
33. Scharf MB, Baumann M, Berkowitz DV. The effect of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003;30:1070-4.
34. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988:41:313-21.
35. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
36. Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835-43.
37. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and interpretation guide. Lincoln, RI: QualityMetric Inc.; 2000.
38. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:728-33.
39. Rechtschaffen A, Kales A, editors. A manual of standardized terminology, techniques and scoring system for sleep stages of human subject. Washington, DC: US Government Printing Office, National Institute of Health Publication; 1968.
40. Rosa AC, Parrino L, Terzano MG. Automatic detection of cyclic alternating pattern (CAP) sequences in sleep: preliminary results. Clin Neurophysiol 1999;110:585-92.
41. Rosa A, Alves GR, Brito M, Lopes MC, Tufik S. Visual and automatic cyclic alternating pattern (CAP) scoring: inter-rater reliability study. Arq Neuropsiquiatr 2006;64:578-81.
42. Russell IJ, Bennett RM, Michalek JE. Oxybate for FMS Study Group. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009:60:299-309.
43. Hume KI, Van F, Watson A. A field study of age and gender differences in habitual adult sleep. J Sleep Res 1998;7:85-94.
44. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med 1993;328:1230-5.
45. George CFP, Feldman N, Zheng Y, Steininger TL, Grzeschik SM, Lai C, et al. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. Sleep Breath 2010 Jan 18; Epub ahead of print.
46. George CFP, Feldman N, Inhaber NH, Steininger TL, Grzeschik SM, Lai C, et al. A safety trial of sodium oxybate in patients with obstructive sleep apnea: acute effects on sleep-disordered breathing. Sleep Med 2010;11:38-42.
47. Feldman NT. Xyrem safety: the debate continues. Sleep Med 2009;10:405-6.